|Bid||13.21 x 100000|
|Ask||13.31 x 100000|
|Day's Range||13.46 - 13.48|
|52 Week Range||11.60 - 21.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
A Milan judge has seized 2.3 million euros ($2.7 million) from pharmaceutical multinational Novartis as part of a fraud investigation, a document seen by Reuters shows. The money has been sequestered from the company's Italian unit Novartis Farma SpA, suspected of selling medicines to hospitals at inflated prices as part of a scheme to fraudulently obtain reimbursement funds from the regional government. Novartis said in a statement it rejected the "groundless" accusations of the Milan prosecutors and had behaved with full transparency.
The pending merger of Pfizer's (PFE) Upjohn unit with Mylan (MYL) is on track to close in the fourth quarter of 2020 as almost all necessary regulatory clearances are in place.
The drugmaker is eager to recast itself as a high-multiple growth stock. The expected growth will be fired up by 25 product launches, which Pfizer is explaining in two days of online talks.